维普中文期刊产品整合服务
49篇 您的检索式:作者名="Hartleb"
    题名 作者 年代 出处 被引量
1Nodular regenerative hyperplasia:Evolving concepts on underdiagnosed cause of portal hypertension显示文摘Nodular regenerative hyperplasia(NRH)is a rare liver condition characterized by a widespread benign transformation of the hepatic parenchyma into small regenerative nodules.NRH may lead to the development of non-cirrhotic portal hypertension.There are no published systematic population studies on NRH and our current knowledge is limited to case reports and case series.NRH may develop via autoimmune,hematological,infectious,neoplastic,or drug-related causes.The disease is usually asymptomatic,slowly or nonprogressive unless complications of portal hypertension develop.Accurate diagnosis is made by histopathology,which demonstrates diffuse micronodular transformation without fibrous septa.Lack of perinuclear collagen tissue distinguishes NRH from typical regenerative nodules in the cirrhotic liver.While the initial treatment is to address the underlying disease,ultimately the therapy is directed to the management of portal hypertension.The prognosis of NRH depends on both the severity of the underlying illness and the prevention of secondary complications of portal hypertension.In this review we detail the epidemiology,pathogenesis,diagnosis,management,and prognosis of NRH.Marek Hartleb Krzysztof Gutkowski Piotr Milkiewicz 2011World Journal of Gastroenterology2011,17,11:16
2Serum adipokines in inflammatory bowel disease显示文摘AIM:To investigate serum adipokine levels in inflammatory bowel disease(IBD)patients before treatment and after achieving clinical remission.METHODS:Serum concentrations of six adipokines(tissue growth factor-β1,adiponectin,leptin,chemerin,resistin,and visfatin)were studied in 40 subjects with active IBD[24 subjects with Crohn’s disease(CD)and in 16 subjects with ulcerative colitis(UC)]before and after three months of therapy with corticosteroids and/or azathioprine.Clinical diagnoses were based on ileocolonoscopy,computed tomography or magnetic resonance enterography and histological examination of mucosal biopsies sampled during endoscopy.Serum levels of adipokines were assessed by an indirect enzyme-linked immunosorbent assay.The control group was comprised of 16 age-and sex-matched healthyvolunteers.RESULTS:Baseline leptin concentrations were significantly decreased in both types of IBD compared to controls(8.0±9.1 in CD and 8.6±6.3 in UC vs 16.5±10.1 ng/mL in controls;P<0.05),and significantly increased after treatment only in subjects with CD(14.9±15.1 ng/mL;P<0.05).Baseline serum resistin concentrations were significantly higher in CD(19.3±12.5ng/mL;P<0.05)and UC subjects(23.2±11.0 ng/mL;P<0.05)than in healthy controls(10.7±1.1 ng/mL).Treatment induced a decrease in the serum resistin concentration only in UC subjects(14.5±4.0 ng/mL;P<0.05).Baseline serum concentrations of visfatin were significantly higher in subjects with CD(23.2±3.2ng/mL;P<0.05)and UC(18.8±5.3 ng/mL;P<0.05)than in healthy controls(14.1±5.3 ng/mL).Treatment induced a decrease in the serum visfatin concentrations only in CD subjects(20.4±4.8 ng/mL;P<0.05).Serum levels of adiponectin,chemerin and tissue growth factor-β1 did not differ between CD and UC subjects compared to healthy controls and also were not altered by anti-inflammatory therapy.Clinical indices of IBD activity did not correlate with adipokine levels.CONCLUSION:IBD modulates serum adipokine levels by increasing resistin and visfatin release and suppressing leptin production.Marek Waluga Marek Hartleb Grzegorz Boryczka Micha Kukla Krystyna Zwirska-Korczala 2014World Journal of Gastroenterology2014,20,22:11
3Kidneys in chronic liver diseases显示文摘Acute kidney injury(AKI),defined as an abrupt increase in the serum creatinine level by at least 0.3 mg/dL,occurs in about 20% of patients hospitalized for decompensating liver cirrhosis.Patients with cirrhosis are susceptible to developing AKI because of the progressive vasodilatory state,reduced effective blood volume and stimulation of vasoconstrictor hormones.The most common causes of AKI in cirrhosis are pre-renal azotemia,hepatorenal syndrome and acute tubular necrosis.Differential diagnosis is based on analysis of circumstances of AKI development,natriuresis,urine osmolality,response to withdrawal of diuretics and volume repletion,and rarely on renal biopsy.Chronic glomerulonephritis and obstructive uropathy are rare causes of azotemia in cirrhotic patients.AKI is one of the last events in the natural history of chronic liver disease,therefore,such patients should have an expedited referral for liver transplantation.Hepatorenal syndrome(HRS) is initiated by progressive portal hypertension,and may be prematurely triggered by bacterial infections,nonbacterial systemic inflammatory reactions,excessive diuresis,gastrointestinal hemorrhage,diarrhea or nephrotoxic agents.Each type of renal disease has a specific treatment approach ranging from repletion of the vascular system to renal replacement therapy.The treatment of choice in type 1 hepatorenal syndrome is a combination of vasoconstrictor with albumin infusion,which is effective in about 50% of patients.The second-line treatment of HRS involves a transjugular intrahepatic portosystemic shunt,renal vasoprotection or systems of artificial liver support.Marek Hartleb Krzysztof Gutkowski 2012World Journal of Gastroenterology2012,18,24:8
4Simultaneous liver mucinous cystic and intraductal papillary mucinous neoplasms of the bile duct:A case report显示文摘Cystic hepatic neoplasms are rare tumors,and are classified into two separate entities:mucinous cystic neoplasms(MCNs)and intraductal papillary mucinous neoplasms of the bile duct(IPMN-B).We report the case of a 56-year-old woman who presented with abdominal pain and jaundice due to the presence of a large hepatic multilocular cystic tumor associated with an intraductal tumor.Partial hepatectomy with resection of extrahepatic bile ducts demonstrated an intrahepatic MCN and an intraductal IPMN-B.This is the first report of the simultaneous occurrence of these two histologically distinct entities in the liver.Agnieszka Budzynska Marek Hartleb Ewa Nowakowska-Dulawa Robert Krol Piotr Remiszewski Michal Mazurkiewicz 2014World Journal of Gastroenterology2014,20,14:2
5Hepatic angiogenesis and fibrosis are common features in morbidly obese patients显示文摘Monika Ciupińska-Kajor Marek Hartleb Maciej Kajor Micha? Kukla Mariusz Wyle?o? Dariusz Lange ?ukasz Liszka 2013Hepatology International2013,,1:1
6Procalci-tonin and macrophage inflammatory protein -1 beta ( MIP -1p) in serum and peritoneal fluid of patients with decompen-sated cirrhosis and spontaneous bacterial peritonitis显示文摘LESINSKA M HARTLEB M GUTKOWSKI K etal 2014AdvMed Sci2014,59,1:1
7Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey – PolSenior显示文摘Marek Hartleb Krzysztof Gutkowski Jan E. Zejda Jerzy Chudek Andrzej Wi?cek 2012European Journal of Gastroenterology & Hepatology2012,,11:1
8Alcoholic liver disease 显示文摘Waluga M Hartleb M 2003Wiad Lek2003,56,12:1
9Coagu- lopathy in liver diseases显示文摘PLUTA A GUTKOWSKI K HARTLEB M 2010Advances in Medical Sci- ences2010,55,:1
10Procalcitonin and macrophage inflammatory protein-1 beta (MIP-113) in serum and peritoneal fluid of patients with decompensated cirrhosis and spontaneous bacterial peritonitis显示文摘Lesi fi ska M Hartleb M Gutkowski K 2014Adv Med Sci2014,59,1:1
11Drug-induced liver damage-a three-year study of patients from one gastroenterological department显示文摘Hartleb M Biernat L Kochel A 2002Med Sci Monit2002,8,4:1
12Vascular hyproresponsiveness to endothelin- 1 in rats with cirrhosis显示文摘Hartleb M Moreau R Cailmail S 1994Gastroenterology1994,107,4:1
13Alcoholic liver disease显示文摘Waluga M Hartleb M 2003W iadLek2003,56,12:1
14Vasculor hy- poresponsiveness to endothelin-1 in rats with cirrhosis显示文摘HARTLEB M MOREAU R CAILMAIL S 1994Gas- troenterology1994,107,4:1
15Coagulopathy in liver diseases 显示文摘Pluta A Gutkowski K Hartleb M 2010Adv Med Sci2010,55,1:1
16Neurogenic tumors of the digestive tract:report of two cases 显示文摘Rymarczyk G Hartleb M Boldys H 2000Med Sci Monit2000,6,2:1
17Coagulopathy in liver diseases显示文摘Pluta A Gutkowski K Hartleb M 0,,01:1
18Vascular hyporesponsiveness to endothelin-1 in rats with cirrhosis 显示文摘14,Hartleb M Moreau K Cailmail S 1994Gastroenterology1994,107,4:1
19Vascular hyporeponsiveness to endothelin in rats with cirrhosis显示文摘 Moreau R Caimail S 1994Gastroenterology1994,107,:1
20Coagulopathy in liver diseases显示文摘A Pluta K Gutkowski M Hartleb 2010Advances in Medical Sciences2010,,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费